The Center for Cancer and Blood Disorders is a clinical research site located in Bethesda, Maryland, United States 20874.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
The Center for Cancer and Blood Disorders has participated in 11 clinical trials with 7 currently active.
Therapeutic areas: Ph+ Acute Lymphoblastic Leukemia (Ph+ALL), Ph- Acute Lymphoblastic Leukemia (Ph-ALL), Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+).
Sponsors: EDDC (Experimental Drug Development Centre), A*STAR Research Entities, Tempus AI, OncoC4, Inc..
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The Center for Cancer and Blood Disorders has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Center for Cancer and Blood Disorders has 11 clinical trials on record, with 7 currently active. Their work covers Ph+ Acute Lymphoblastic Leukemia (Ph+ALL), Ph- Acute Lymphoblastic Leukemia (Ph-ALL), Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+).
Yes — The Center for Cancer and Blood Disorders holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.